Holen Sie sich die Stockscreener-App
19.77
0.85%
-0.17
Schlusskurs vom Vortag:
$19.94
Offen:
$19.94
24-Stunden-Volumen:
209.45K
Relative Volume:
0.48
Marktkapitalisierung:
$733.38M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.89%
1M Leistung:
-13.25%
6M Leistung:
+65.99%
1J Leistung:
-9.73%
1-Tages-Spanne:
$19.71
$20.71
1-Wochen-Bereich:
$19.40
$21.95
52-Wochen-Spanne:
$10.01
$26.04
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
19.77 | 739.69M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-24 | Eingeleitet | BTIG Research | Buy |
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
CeriBell, Inc. (CBLL) Stock Analysis: A 41% Upside Potential In Revolutionary Medical Devices - DirectorsTalk Interviews
What drives CeriBell Inc.’s stock price2025 Big Picture & Capital Protection Trade Alerts - mfd.ru
Market Overview: How sensitive is CeriBell Inc to inflation2025 Price Targets & Weekly Return Optimization Alerts - baoquankhu1.vn
FMR LLC Reduces Stake in CeriBell Inc: A Strategic Portfolio Adj - GuruFocus
Is CeriBell Inc. forming a breakout pattern2025 Geopolitical Influence & Entry and Exit Point Strategies - mfd.ru
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - The Manila Times
Ceribell Inc introduces new neonatal EEG at NEO Pediatrix event - Traders Union
Ceribell, Inc. shows power of POCEEG in seizure detection - Traders Union
Ceribell CEO Chao Xingjuan sells $786k in shares - Investing.com
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 5,556 Shares - MarketBeat
New medical partner - Northwest Indiana Business Magazine
What are the future prospects of CeriBell IncPortfolio Update Summary & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What is CeriBell Incs 5 year growth outlook2025 Dividend Review & Trade Opportunity Analysis Reports - baoquankhu1.vn
What is CeriBell Inc. s revenue forecastJuly 2025 Breakouts & Weekly Return Optimization Alerts - mfd.ru
Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook - TipRanks
BTIG Reiterates Buy Rating for CeriBell (CBLL) with $30 Price Ta - GuruFocus
Forecasting The Future: 5 Analyst Projections For CeriBell - Benzinga
Income Plays: Is CeriBell Inc a top pick in the sectorWeekly Loss Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Fed Meeting: What are the risks of holding CeriBell Inc2025 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn
What’s the profit margin of CeriBell Inc.Analyst Upgrade & Safe Entry Trade Reports - mfd.ru
CeriBell, Inc. $CBLL Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Ceribell director resigns to pursue other professional ventures - MSN
CeriBell, Inc. (CBLL) Stock Analysis: A 24% Potential Upside Beckons in the Dynamic Medical Device Sector - DirectorsTalk Interviews
Targets Report: Is Bolt Projects Holdings Inc stock a buy or sellPortfolio Return Summary & Entry and Exit Point Strategies - baoquankhu1.vn
Ceribell director Parvizi sells $573k in shares By Investing.com - Investing.com South Africa
Josef Parvizi Sells 25,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell director Parvizi sells $573k in shares - Investing.com
CeriBell a new buy at BTIG on growth in EEG monitoring system - MSN
FDA clearances: Siemens Healthineers, Medtronic, CeriBell - Modern Healthcare
Risk Hedge: Does CeriBell Inc stock reflect fundamentalsJuly 2025 Levels & Daily Chart Pattern Signal Reports - baoquankhu1.vn
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion - Yahoo Finance
Growth Value: Does CeriBell Inc have consistent dividend growthAnalyst Downgrade & Real-Time Market Trend Scan - baoquankhu1.vn
Protara, Ceribell rise on FDA breakthrough designations - MSN
CBLL: FDA-cleared AI neuromonitoring expands to pediatrics and delirium, driving growth and efficiency - TradingView
CBLL: 2026 growth will accelerate with new FDA clearances, VA expansion, and pediatric launches - TradingView — Track All Markets
Ceribell sues Natus Medical for patent infringement - MSN
CeriBell, Inc. (NASDAQ:CBLL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Ceribell shares advance after FDA grants breakthrough device status - MSN
CeriBell, Inc.'s (NASDAQ:CBLL) Shares May Have Run Too Fast Too Soon - simplywall.st
CeriBell, Inc. (CBLL) Stock Analysis: Healthcare Innovator With A 21.99% Upside Potential - DirectorsTalk Interviews
Is CeriBell Inc. stock a buy on dips2025 Top Decliners & Long-Term Safe Return Strategies - Улправда
Is CeriBell Inc. stock attractive for retirement portfoliosOptions Play & AI Driven Price Predictions - ulpravda.ru
Will CeriBell Inc. stock rally after Fed decisions2025 Key Highlights & Reliable Intraday Trade Plans - ulpravda.ru
Aug Technicals: Why CeriBell Inc. stock could outperform in 2025Portfolio Risk Summary & High Return Trade Opportunity Guides - ulpravda.ru
FDA clearances and approvals: J&J, Abbott, Edwards Lifesciences - Modern Healthcare News
Ceribell’s Foehr sells $125k in shares after option exercise By Investing.com - Investing.com Nigeria
Xingjuan Chao Sells 79,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell CEO Chao Xingjuan sells $1.68 million in shares By Investing.com - Investing.com South Africa
Ceribell CEO Chao Xingjuan sells $1.68 million in shares - Investing.com
Pittsburgh Post-GazetteCeriBell, Inc.Common Stock (Nasdaq:CBLL) Detailed Stock Data - FinancialContent
Will CeriBell Inc. stock benefit from infrastructure spendingFootwear buying guidance for recovery days and low impact training focuses on balanced cushioning and support, making it a solid option for daily use. - ulpravda.ru
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Es liegen keine Finanzdaten für Ceribell Inc (CBLL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):